Releases
Found 20301 articles
Blood Test Predicts Alzheimer's Risk Decade Before Symptoms Emerge
A simple blood test measuring the protein p-tau217 can identify older adults at high risk of developing Alzheimer's disease up to ten years before cognitive symptoms appear. Presented at the 2026 Alzheimer's Association International Conference, the findings suggest a shift toward proactive screening similar to monitoring cholesterol levels.
Geely Cyan Racing Dominates European Leg of 2026 TCR World Tour
A dominant performance in the narrow, winding streets of Vila Real, Portugal, secured Geely Cyan Racing its fifth victory of the 2026 Kumho FIA TCR World Tour. French driver Yann Ehrlacher claimed the win in Race 1, propelling the team to a commanding 56-point lead in the overall standings.
Casio Expands G-SHOCK Brand into the Roblox Metaverse
With over 150 million daily users, Roblox is becoming the new proving ground for G-SHOCK’s durability. Casio is entering the platform with a dedicated virtual world and a collection of digital timepieces, aiming to bridge the gap between street culture aesthetics and the next generation of digital-native consumers.
Q32 Bio Prices $200 Million Stock Offering for Autoimmune Research
Waltham-based Q32 Bio has priced a $200 million public offering of common stock and pre-funded warrants, aiming to bolster its clinical pipeline. The biotechnology firm is selling over 6 million common shares at $18.25 each, with proceeds earmarked to accelerate the development of its lead candidate, bempikibart.
Casio Expands Virtual G-SHOCK Presence to Roblox
With over 150 million daily active users, Roblox has become the latest arena for Casio’s VIRTUAL G-SHOCK project. Starting July 15, the watchmaker will integrate its iconic timepiece designs and a custom skateboarding obstacle course into the platform, aiming to capture the attention of a younger, digital-native demographic.
Registered Behavior Technician Sues Corona-Norco District Over Retaliation
Alejandrina King, a Registered Behavior Technician, is set to challenge the Corona-Norco Unified School District in court following her alleged wrongful termination. Represented by civil rights attorney John Gomez, King claims she faced a hostile work environment after flagging systemic failures to follow legally mandated special education protocols.
Monteverde & Associates Scrutinizes Four Upcoming Shareholder Votes
With shareholder votes looming for four major corporate transactions, New York-based Monteverde & Associates PC is urging investors to weigh their options before casting ballots. Attorney Juan Monteverde, whose firm was ranked in the 2025 ISS Securities Class Action Services Report, is currently investigating the fairness of these pending mergers and acquisitions.
IBM Faces Investor Scrutiny After Q2 Revenue Miss
A 24% single-day collapse in International Business Machines shares has triggered a formal investigation by law firm Levi & Korsinsky. The inquiry centers on whether corporate leadership misled shareholders regarding growth projections for the company's Software and Infrastructure segments during the second quarter of 2026.
A Push for Structural Reform Beyond the Partisan Divide
While 77 percent of Americans report being sidelined by the current political establishment since the 2024 election, a new coalition is attempting to bypass partisan gridlock. A fresh YouGov poll indicates that 83 percent of voters now demand that Congress prioritize a sweeping package of 39 historic political and economic reforms.
Investors Target Embecta Corp. Following Massive Earnings Miss
A 61% plunge in quarterly earnings has triggered a securities class action lawsuit against Embecta Corp., with Hagens Berman investigating whether the medical device manufacturer misled shareholders about the stability of its core pen needle business throughout late 2025 and early 2026.
Erasca Faces Class Action Lawsuit After Patent Dispute and Patient Death
A 48% collapse in share price has triggered a securities class action against Erasca, Inc., following revelations of a patent infringement claim by rival Revolution Medicines and the death of a patient participating in a clinical trial for the company’s experimental cancer drug, ERAS-0015.
LumaCina Appoints Industry Veteran Gary Bird as CEO
Gary Bird has been named Chief Executive Officer of LumaCina, a Perth-based pharmaceutical supplier, as the company pivots toward international expansion. The appointment aims to leverage Bird’s three decades of experience in the Australian pharmaceutical sector to scale the firm’s sterile injectables portfolio across global hospital markets.
Black Rock Coffee Faces Class Action Over IPO Disclosures
Investors who bought Black Rock Coffee Bar shares following the company’s September 2025 initial public offering are now seeking legal recourse. A class action lawsuit alleges that the coffee chain misled shareholders regarding its aggressive growth strategy, which has since seen share prices plummet more than 60 percent.
Hub Group Faces Class Action Suit Over Accounting Errors
Investors who held Hub Group, Inc. stock between April 2023 and May 2026 are now eligible to join a class action lawsuit following the company's admission that years of financial reports were materially misstated. The litigation, led by Hagens Berman, targets alleged accounting failures that eroded nearly $900 million in market value.
Peabody Energy Faces Class Action Over Centurion Mine Production Claims
A 36% plunge in Peabody Energy’s stock price has triggered a securities class action lawsuit, as investors allege the company misled them regarding the operational status and production capabilities of its flagship Centurion metallurgical coal mine in Queensland, Australia.
Photronics Faces Securities Class Action After Stock Plunge
A 36% single-day collapse in Photronics, Inc. share prices on May 28, 2026, has triggered a securities class action lawsuit. Investors allege that company management misled the market regarding the health of its high-end integrated circuit photomask business, masking operational bottlenecks with optimistic growth projections throughout the first half of the year.
Commvault Investors Face July 17 Deadline in Expanded Securities Lawsuit
Investors in Commvault Systems have until July 17, 2026, to file as lead plaintiffs in an expanded class action lawsuit. The litigation claims the company misled shareholders regarding its competitive position and the financial impact of shifting toward a SaaS-heavy sales model throughout 2025.
PG&E Prepares Power Shutoffs Across 10 Counties Amid High Wind Risks
Pacific Gas and Electric Company is bracing for its third Public Safety Power Shutoff of 2026, targeting approximately 7,800 customers across Northern and Central California. The preemptive de-energization is scheduled to begin Wednesday afternoon as high winds, low humidity, and dry vegetation create an elevated risk for wildfires.
Investors Face July 17 Deadline in Sportradar Securities Lawsuit
Investors who held Sportradar Group AG shares between November 2024 and April 2026 have until July 17 to join a securities class action investigation. The legal push follows a 22% single-day stock collapse triggered by allegations that the firm knowingly profited from black-market gambling operations.
Hagens Berman Investigates PicS IPO Disclosure Allegations
Investors who suffered losses following the PicS N.V. initial public offering face an August 4, 2026, deadline to seek lead plaintiff status in a class action lawsuit. The litigation targets alleged misrepresentations regarding the company’s internal credit evaluation procedures and the actual financial health of its asset portfolio.
Veritone Faces Class Action Over Accounting Irregularities
Investors who suffered losses in Veritone, Inc. between October 14, 2025, and April 14, 2026, are being sought for a securities class action lawsuit. The litigation targets the company for allegedly issuing materially misstated financial reports and failing to maintain adequate internal accounting controls.
GRAIL Faces Securities Litigation Following Trial Failure
A $2.2 billion collapse in market capitalization has triggered a class action lawsuit against GRAIL, Inc. The litigation, led by Hagens Berman, targets the healthcare firm for allegedly misleading investors regarding the design and projected success of its NHS-Galleri cancer detection trial during the 2025-2026 class period.
Verra Mobility Faces Class Action Lawsuit After $1.4 Billion Stock Plunge
Investors who suffered significant losses in Verra Mobility Corp. have until August 4, 2026, to seek lead plaintiff status in a securities class action. The legal challenge follows a brutal 70% share price collapse sparked by the abrupt termination of a critical contract with Avis Budget Group.
Senhwa Biosciences Secures NT$500 Million Investment from GEM
Senhwa Biosciences has entered a share purchase agreement with GEM Global Yield LLC SCS, securing a commitment of up to NT$500 million, or approximately US$15.5 million, to fund the company’s oncology research and clinical development pipeline over the next three to five years.
Corgi Insurance Enters $600 Billion Sports Market with Golden
Behind every multi-billion dollar stadium and professional roster lies a complex, often fragmented web of insurance policies. San Francisco-based Corgi Insurance is attempting to consolidate this market with the launch of Golden, a specialized vertical designed to replace outdated brokerage stacks with a single, tech-driven platform for sports organizations.
LONGi Secures Spot on S&P Global 2026 Tier 1 Cleantech List
For the second consecutive year, Xi'an-based LONGi Green Energy Technology has earned a place among the world’s elite cleantech suppliers. The company is one of only 15 global firms to meet the rigorous six-point criteria set by S&P Global Energy for its 2026 Tier 1 classification.
Investors Scrutinize Blaize Holdings Amid Fraud Allegations
A 12% single-day collapse in Blaize Holdings stock on April 28, 2026, has triggered a formal investigation by the Rosen Law Firm. The firm is examining potential securities claims following allegations that the company misled shareholders regarding the legitimacy of a $50 million deal with NeoTensr.
Insilico Medicine and Bora Pharmaceuticals Form AI Drug Discovery Pact
Insilico Medicine and Bora Pharmaceuticals have launched a strategic alliance to integrate AI-driven molecule discovery with large-scale manufacturing and commercial infrastructure. The partnership seeks to overhaul traditional pharmaceutical development, with potential deal values exceeding US$2.5 billion as the firms push toward an AI-native innovation model.
Hitachi’s Oklahoma Storage Facility Named Global Lighthouse Factory
The World Economic Forum has designated Hitachi Vantara’s manufacturing plant in Norman, Oklahoma, as a Lighthouse facility. The award recognizes the site’s integration of agentic AI and robotics, marking the second time a Hitachi Group location has earned the distinction for leading Fourth Industrial Revolution technologies.
Lynk Pharmaceuticals Completes Enrollment for Ankylosing Spondylitis Trial
Lynk Pharmaceuticals has finalized enrollment for its Phase III clinical trial of zemprocitinib, an oral treatment targeting active ankylosing spondylitis. By securing 352 participants, the company moves closer to offering a potential alternative for patients who struggle with current inflammatory disease therapies and their associated long-term safety concerns.